Edesa Biotech, Inc. - Common Shares, without par value (EDSA) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2023 to Q4 2025

Type / Class
Equity / Common Shares, without par value
Symbol
EDSA on Nasdaq
Shares outstanding
8,333,333
Price per share
$0.98
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
3,052,670
Total reported value
$4,339,133
% of total 13F portfolios
0%
Share change
+175,962
Value change
+$168,466
Number of holders
21
Price from insider filings
$0.98
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Edesa Biotech, Inc. - Common Shares, without par value (EDSA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nijhawan Pardeep 20% 0% $2,510,166 +$546,371 2,040,785 +28% Pardeep Nijhawan 26 Feb 2026
Nantahala Capital Management, LLC 10% 0% $1,266,263 +$229,541 855,583 +22% Nantahala Capital Management, LLC 31 Dec 2025
Velan Capital Investment Management LP 10% 0% $1,026,681 +$173,613 834,700 +20% Velan Capital Investment Management LP 26 Feb 2026
Stonepine Capital Management, LLC 9.9% $1,636,780 693,551 Stonepine Capital Management, LLC 13 Feb 2025
Point72 Asset Management, L.P. 7.2% $588,000 600,000 Point72 Asset Management, L.P. 24 Feb 2026

As of 31 Dec 2025, 21 institutional investors reported holding 3,052,670 shares of Edesa Biotech, Inc. - Common Shares, without par value (EDSA). This represents 37% of the company’s total 8,333,333 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Edesa Biotech, Inc. - Common Shares, without par value (EDSA) together control 37% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Velan Capital Investment Management LP 8.3% 687,500 0% 0.57% $976,250
Stonepine Capital Management, LLC 8.3% 687,500 0% 0.78% $976,250
Rubric Capital Management LP 8.3% 687,500 0% 0.01% $976,250
Nantahala Capital Management, LLC 7.5% 625,000 0% 0.05% $887,500
DRW Securities, LLC 1.6% 134,222 0.01% $190,595
DIADEMA PARTNERS LP 0.65% 54,025 0.05% $76,716
CITADEL ADVISORS LLC 0.64% 53,630 +282% 0% $77,764
GEODE CAPITAL MANAGEMENT, LLC 0.56% 46,537 +2.9% 0% $67,484
VANGUARD GROUP INC 0.45% 37,600 -17% 0% $54,520
STATE STREET CORP 0.22% 18,679 0% $27,085
Persistent Asset Partners Ltd 0.15% 12,319 0.01% $17,493
Tower Research Capital LLC (TRC) 0.03% 2,554 +100% 0% $3,627
MORGAN STANLEY 0.03% 2,300 0% $3,266
ROYAL BANK OF CANADA 0.02% 1,659 -8.6% 0% $2,000
UBS Group AG 0.02% 1,362 -25% 0% $1,934
TD Waterhouse Canada Inc. 0% 142 0% 0% $200
Global Retirement Partners, LLC 0% 86 +244% 0% $122
BANK OF AMERICA CORP /DE/ 0% 52 +2% 0% $74
LRI Investments, LLC 0% 1 0% 0% $1
DANSKE BANK A/S 0% 1 0% 0% $1
Dogwood Wealth Management LLC 0% 1 0% 0% $1
CITIGROUP INC 0% 0 -100% $0
RENAISSANCE TECHNOLOGIES LLC 0% 0 -100% $0
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0% 0 -100% $0
BARCLAYS PLC 0% 0 -100% $0

Institutional Holders of Edesa Biotech, Inc. - Common Shares, without par value (EDSA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 3,052,670 $4,339,133 +$168,466 $1.42 21
2025 Q3 2,876,709 $7,101,619 +$1,897,089 $2.47 23
2025 Q2 2,108,117 $4,279,068 -$1,739,763 $2.03 20
2025 Q1 2,822,207 $6,885,740 +$6,475,156 $2.44 19
2024 Q4 207,513 $350,110 +$46,292 $1.68 16
2024 Q3 161,348 $718,217 +$49,169 $4.45 17
2024 Q2 150,715 $645,126 +$183,339 $4.28 17
2024 Q1 107,880 $450,876 -$12,949 $4.19 17
2023 Q4 110,845 $507,117 +$507,117 $4.57 19